deltatrials
Completed PHASE2 NCT00000602

Pediatric Hydroxyurea in Sickle Cell Anemia (PED HUG)

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Conditions Anemia, Sickle Cell Hematologic Diseases Hemoglobinopathies
Interventions hydroxyurea
Updated 5 times since 2017 Last updated: Sep 15, 2016 Started: Apr 30, 1994 Completion: Mar 31, 1997

Listed as NCT00000602, this PHASE2 trial focuses on Anemia, Sickle Cell and Hematologic Diseases and remains completed. Sponsored by National Heart, Lung, and Blood Institute (NHLBI), it has been updated 5 times since 1994, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE2

    First recorded

Apr 1994

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Heart, Lung, and Blood Institute (NHLBI)
Data source: National Heart, Lung, and Blood Institute (NHLBI)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.